Sudarshan Pharma Industries Limited

Company Profile
Company Name Sudarshan Pharma Industries Limited
Open Date 09-03-2023
Close Date 14-03-2023
Exchange NSE SME
Lot Size 1600 Shares
Issue Price ₹ 71 to 73 per share
Issue Size 68,62,400 Equity Shares
Application Amount ₹ 1,16,800
Recommendation Risk_Averse - Should Wait Risk_Seekers - Should Apply
Company was formed in Maharashtra in the year 2008. Company’s core business is Specialty Chemicals & Intermediates for Pharma, Agro chemicals, Coating, paints, adhesive and various other industries. Company is also into Active Pharmaceuticals Ingredients manufacturing which company outsource to a manufacturer at their toll manufacturing facility, Company is also into specialty chemicals imports & exports as well as supply of same to the actual users. Company is also involved in Contract Manufacturing, Outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. Company operates both in domestic and international markets. Management is planning for business expansion by having its own state of the art manufacturing facility at Mahad along with its mini manufacturing facility at Wada Area, Formulation GMP unit at Tarapur, Maharashtra. It also plans to develop distributor network & logistic facility in Mumbai, Delhi, Chennai, Hyderabad and Ahmedabad. Company has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable. Management has made separate division – Vimac Healthcare to focus on Branding of Pharmaceutical Formulation and medicines.
(Read more on the review)

Summary of Financials (All financials in lakhs)

For the Period Ended Mar-21 Mar-22 Sep-22
Total Assets 9,926.02 13,752.18 16,402.22
Net Assets 2,250.75 2,977.53 5,108.79
Total Borrowings 2,977.09 3,059.24 4,940.51
Total Revenue 19,372.80 35,755.89 19,589.87
Profit After Tax 267.12 530.36 360.70

Tentative Timeline

Opening Date 09-03-2023
Closing Date 14-03-2023
Basis of Allotment 17-03-2023
Initiation of Refunds 20-03-2023
Credit of Shares to Demat 21-03-2023
Listing Date 22-03-2023

Objects of the Issue

Working Capital Requirements;
General Corporate Purposes.

Contact Information

Registered Office Sudarshan Pharma Industries Ltd 301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai - 400092.
Phone 022- 42221111

Registrar Details

Name Kfin Technologies Limited
Phone 04067162222, 04079611000

IPO Reservation

Anchor Investor Shares Offered 7,80,800 (10.83%)
Market Maker Shares Offered 3,44,000 (4.77%)
QIB Shares Offered 5,21,600 (7.24%)
NII (HNI) Shares Offered 19,08,800 (26.49%)
Retail Shares Offered 36,51,200 (50.67%)
Total Shares Offered 72,06,400 (100%)

Shareholding Pattern

Share Holding Pre Issue (Promoters) 80.28%
Share Holding Post Issue (Promoters) 57.38%

Contact Us to Enable Your Success!